Aminals
Medchemexpress LLC TRAIL/TNFSF10 Trimer 20ug | 20ug
TRAIL Protein (TNFSF10) a member of the TNF superfamily is a type II transmembrane protein TRAIL Protein mainly interacts with TRAIL-R1 and TRAIL-R2 and induces apoptosis in tumor or infected cells TRAIL Protein also binds with DR4 DR5 and OPG TRAIL Protein can recruit FADD and further recruit and activates caspase-8 after binding to DR4 or DR5 Besides TRAIL may also trigger nonapoptotic signaling through activating pro-inflammatory pathways[1][2] TRAIL protein is mainly expressed on surface of immune cells such as cytotoxic T cells and natural killer (NK) cell[1] TRAIL/TNFSF10 Protein Human (HEK293 His-Flag) is a recombinant human TRAIL (G118-G281) with N-terminal His and Flag tag which is expressed in HEK293
Medchemexpress LLC TL1A/TNFSF15 Trimer 2ug | 2ug
The TL1A protein (VEGI protein) belongs to the tumor necrosis factor (TNF) family and is a receptor for TNFRSF25 and TNFRSF6B TL1A is involved in the activation of NF- B and C-Jun pathways which can be used as a regulator of mucosal immunity and participate in the immune pathway of inflammatory bowel disease (IBD) pathogenesis[1][2] TL1A originates from endothelial cells and inhibits the proliferation of breast cancer epithelial and myeloid tumor cells[3] The human TL1A protein has a transmembrane domain (36-56 a a ) that can be cleaved into membrane-type and soluble peptide fragments TL1A/TNFSF15 Trimer Protein Human (HEK293 His-Flag) is the extracullar part of TL1A protein (D91-L251) produced in HEK293 cells with N-terminal His- and Flag-tag
Medchemexpress LLC Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:19) | 8064-90-2 | 99.8% | C24H29N7O6S | 1 G
Cotrimoxazole (Trimethoprim/sulfamethoxazole 1:19) is an antimicrobial agent that is a mixture of Trimethoprim and Sulfamethoxazole with a 1:19 ratio. It is a stable solid, typically white to off-white in appearance, and is suitable for laboratory research.
- Antimicrobial agent
- Mixture of Trimethoprim and Sulfamethoxazole
- Stable under recommended storage conditions
- White to off-white solid appearance
- For research use only
Medchemexpress LLC Larsucosterol trimethylamine | 00-00-0 | 97.0% | C27H46O5S·0.45C3H9N | 10MG
Larsucosterol trimethylamine is a cholesterol metabolite used as a research reagent. It acts as a potent liver X receptor (LXR) antagonist and modulates lipid metabolism by decreasing lipogenesis and inhibiting cholesterol biosynthesis through reduced SREBP-1 activation. The compound is supplied in high-purity forms for laboratory assays, available as small solid quantities or ready-to-use DMSO solutions.
- Potent liver X receptor (LXR) antagonist
- Modulates lipid metabolism by decreasing lipogenesis
- Inhibits cholesterol biosynthesis via reduced SREBP-1 activation
- High purity (97.0%) suitable for research use
- Available in small solid quantities and DMSO solutions for assays
Electron Microscopy Sciences Hexamethylenetetramine 25 GR
(Urotropine; Methenamine)
CAS #100-97-0 C₆N₄ F.W. 140.19
Assay: 99.0-100.5%
Hexamethylenetetramine (Urotropine; Methenamine) is used in silver stains. Hexamethylenetetramine in 25 ml bottles is not classified as a hazardous chemical for shipping purposes.
Medchemexpress LLC Larsucosterol (trimethylamine) | 97.0% | 509.32 | 1 ML
Larsucosterol (trimethylamine), also known as DUR-928 (trimethylamine), is a cholesterol metabolite that functions as a potent liver X receptor (LXR) antagonist. It serves as an endogenous regulator to decrease lipogenesis and inhibits cholesterol biosynthesis by reducing mRNA levels and inhibiting the activation of SREBP-1.
- Potent liver X receptor (LXR) antagonist
- Decreases lipogenesis
- Inhibits cholesterol biosynthesis by reducing mRNA levels and activating SREBP-1
- Increases cell proliferation and decreases apoptosis in macrophages
- Protects the liver from injury by suppressing hepatic inflammation